A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patientswith advanced multiple myeloma

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2024-09-12
DOI
https://doi.org/10.3324/haematol.2024.286124
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patientswith advanced multiple myeloma

Matthias Obenaus, Antonio Pezzutto, Martin Vaegler, Jan Krönke et al.
Haematologica
CAR-T cell therapy research
article

A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patientswith advanced multiple myeloma

Matthias Obenaus, Antonio Pezzutto, Martin Vaegler, Jan Krönke, Ulrich Bernd Keller, Thomas J. F. Blankenstein, Dana Hoser, Ann‐Christin von Brünneck, Vivian Scheuplein, Korinna Jöhrens, Igor Wolfgang Blau, Gerald Willimsky, Elisa Kieback, Axel Nogai, Josefine Krüger, Antonia Busse, Ioannis Anagnostopoulos, Hana Rauschenbach, Judith Böhme
article en

Abstract

No abstract available for this paper.
HaematologicaVol. 110(1)
Max Delbrück Center (DE), Heidelberg University (DE), Humboldt-Universität zu Berlin (DE), German Cancer Society (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Bundesministerium für Bildung und Forschung, Medizinischen Hochschule Hannover
Good health and well-being
Openalex Percentile: Top 74%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patientswith advanced multiple myeloma — Matthias Obenaus, Antonio Pezzutto, et al. · Haematologica (2024) | TGRS Research Map | TGRS